These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1509831)

  • 1. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1992; 114(7):333-50. PubMed ID: 1509831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postmenopausal osteoporosis from the viewpoint of the gynecologist].
    Dören M; Schneider HP
    Z Gesamte Inn Med; 1992 Dec; 47(12):568-72. PubMed ID: 1285464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
    Menon KV; Angulo P; Boe GM; Lindor KD
    Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.
    Slemenda C; Longcope C; Peacock M; Hui S; Johnston CC
    J Clin Invest; 1996 Jan; 97(1):14-21. PubMed ID: 8550826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
    Schacht E
    Z Rheumatol; 1994; 53(5):274-98. PubMed ID: 7810237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
    Hodsman AB
    Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Gynakologe; 1993 Apr; 26(2):83-92. PubMed ID: 8508989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differential osteoporosis diagnosis in the woman].
    Lippuner K; Jaeger P
    Ther Umsch; 1998 Nov; 55(11):685-95. PubMed ID: 9865145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.